PD07 - TNF-α and hypoxia alter the expression of ASM cell contractile protein genes by Nikolaos Tsiougkos et al.
POSTER DISCUSSION PRESENTATION Open Access
PD07 - TNF-a and hypoxia alter the expression of
ASM cell contractile protein genes
Nikolaos Tsiougkos*, Stamatina Tsapournioti, Paschalis-Adam Molyvdas, Efrosyni Paraskeva
From 3rd Pediatric Allergy and Asthma Meeting (PAAM)
Athens, Greece. 17-19 October 2013
Background
Recent research on airway smooth muscle (ASM) cell
biology and function has significantly broadened our
understanding of the role these cells play in asthma.
Apart from being structural contractile cells, they also
have immunomodulatory properties. Dynamic multi-
functional behavior of ASM cells, namely phenotype
plasticity and functional diversity, is now-recognized to
be directly involved with tissue inflammation that often
interrelates with hypoxia in orchestrating airway remo-
deling and hyperresponsiveness characteristic of asthma.
Objective
Herein, we sought to investigate the effect of the inflam-
matory mediator TNF-a and/or hypoxia on the expression
of the ASM cell contractile markers SMMHC (smooth
muscle myosin heavy chain), MLCK (myosin light chain
kinase), a2 actin and SM22.
Method
Primary in vitro differentiated human bronchial ASM cell
cultures were incubated for 24 hours in the presence or
absence of TNF-a under normoxia or hypoxia. Total
RNA was extracted, reverse transcribed and mRNA
expression levels of SMMHC, MLCK, a2 actin and SM22
were determined by quantitative real-time PCR.
Results
TNF-a remarkably increased SMMHC mRNA expres-
sion under both normoxia and hypoxia. Treatment
under hypoxia, with TNF-a, or their combination
decreased MLCK and SM22 mRNA levels. In contrast,
a2 actin mRNA levels were not significantly affected
under any of these conditions.
Conclusion
TNF-a and hypoxia appear to alter the expression of
human bronchial ASM cell contractile protein genes, pro-
viding new insights on the complex role of ASM cells in
the pathophysiology of asthma. Remarkable up-regulation
of SMMHC mRNA by TNF-a is indicative of the exces-
sive ASM hypertrophy in severe asthma.
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